Christobel Selecky, Director at ImmunityBio, Inc. (IBRX), sold 25,000 shares at $10.00 ($250K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Open-market sale of $250k IBRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IBRX | SELL | 2026-01-21 | $625K | — | Filing → |